Results 21 to 30 of about 23,167 (255)

Transcriptional Regulation of Autophagy Genes via Stage-Specific Activation of CEBPB and PPARG during Adipogenesis: A Systematic Study Using Public Gene Expression and Transcription Factor Binding Datasets

open access: yesCells, 2019
Autophagy is the cell self-eating mechanism to maintain cell homeostasis by removing damaged intracellular proteins or organelles. It has also been implicated in the development and differentiation of various cell types including the adipocyte.
Mahmoud Ahmed   +5 more
doaj   +1 more source

Nocturnin: a circadian target of Pparg‐induced adipogenesis [PDF]

open access: yesAnnals of the New York Academy of Sciences, 2010
Nuclear receptors (NRs) control cell fate and regulate tissue function. Some of the NRs are expressed in a circadian and tissue‐specific manner. Clock genes are part of the circadian network and fine‐tune gene expression in adipose and skeletal tissues.
Kawai, M   +5 more
openaire   +2 more sources

PPARG Could Work as a Valid Therapeutic Strategy for the Treatment of Lung Squamous Cell Carcinoma

open access: yesPPAR Research, 2020
Previous studies showed that PPAR-gamma (PPARG) ligands might serve as potential therapeutic agents for nonsmall cell lung cancer (NSCLC). However, a few studies reported the specific relationship between PPARG and lung squamous cell carcinoma (LSCC ...
Shunbin Shi   +5 more
doaj   +1 more source

Control of PPARG by NOD2.

open access: yes, 2023
We provide evidence here from overexpression-based gain-of-function studies in human cells (1, 2) which demonstrate control of peroxisome proliferator-activated receptor gamma, PPARG, by the NLR (nucleotide-binding oligomerization domain-like receptor) family protein NOD2.
openaire   +1 more source

A Pharmacogenetic Approach to the Treatment of Patients With PPARG Mutations [PDF]

open access: yesDiabetes, 2018
Loss-of-function mutations in PPARG cause familial partial lipodystrophy type 3 (FPLD3) and severe metabolic disease in many patients. Missense mutations in PPARG are present in ∼1 in 500 people. Although mutations are often binarily classified as benign or deleterious, prospective functional classification of all missense PPARG variants suggests that ...
Agostini, Maura   +17 more
openaire   +4 more sources

Development of metabolic syndrome at a young age as a manifestation of familial partial lipodystrophy type 3 (PPARG mutation): the first description of its clinical case in Russia

open access: yesСахарный диабет, 2015
Metabolic syndrome (MS) is extremely common (20%–25% of the world’s population), and its diagnostic criteria are defined and well known. It has been shown that patients who have MS are twice as likely to die from a cardiovascular complication and three ...
Ekaterina Leonidovna Sorkina   +7 more
doaj   +1 more source

PPARG Drives Molecular Networks as an Inhibitor for the Pathologic Development and Progression of Lung Adenocarcinoma

open access: yesPPAR Research, 2020
Previous studies showed that low PPARG expression was associated with poor prognosis of lung adenocarcinoma (LA) with limited mechanisms identified. We first conducted a large-scale literature-based data mining to identify potential molecular pathways ...
Min Zhao   +5 more
doaj   +1 more source

Cotranscription and intergenic splicing of the PPARG and TSEN2 genes in cattle [PDF]

open access: yesBMC Genomics, 2006
Abstract Background Intergenic splicing resulting in the combination of mRNAs sequences from distinct genes is a newly identified mechanism likely to contribute to protein diversity. Few cases have been described, most of them involving neighboring genes and thus suggesting a cotranscription event presumably due to ...
Roux, Matthieu   +2 more
openaire   +5 more sources

Anthocyanin-Containing Purple Sweet Potato (Ipomoea batatas L.) Synbiotic Yogurt Inhibited 3T3-L1 Adipogenesis by Suppressing White Adipocyte-Specific Genes

open access: yesJournal of Experimental Pharmacology, 2023
Eko Fuji Ariyanto,1 Widad Aghnia Shalannandia,2 Uci Ary Lantika,3 Taufik Muhammad Fakih,4 Dwi Syah Fitra Ramadhan,5 Arini Nurisydayanti Gumilar,6 Farhan Khalil Permana,6 Anisa Nadia Rahmah,6 Nur Atik,2 Astrid Feinisa Khairani2 1Division of Biochemistry ...
Ariyanto EF   +9 more
doaj  

MicroRNA-27b-3p Promotes Tumor Progression and Metastasis by Inhibiting Peroxisome Proliferator-Activated Receptor Gamma in Triple-Negative Breast Cancer

open access: yesFrontiers in Oncology, 2020
Introduction: The role and underlying mechanisms of miR-27b-3p in triple-negative breast cancer (TNBC) remains unclear.Methods: miR-27b-3p expression level was evaluated in 99 TNBC patients with a median follow-up time of 133 months.
Song-Jie Shen   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy